The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Single Mutation in H5N1 Influenza Surface Protein Could Enable Easier Human Infection Dec. 6, 2024 — A single modification in the protein found on the surface of the highly pathogenic avian ...

Bird flu was first detected in domestic birds in 1996 in Southern China and has since spread to wild birds, mammals, and humans worldwide, with a fatality rate reaching 50% in some cases. In the U.S., cases have been mostly mild, affecting primarily poultry and dairy workers, until this recent death in Louisiana.

Last Friday, HHS announced it will provide approximately $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines and enhance mRNA platform capabilities so the U.S. is better prepared to respond to other emerging infectious diseases, according to a release from HHS.

The first human death from bird flu in the United States occurred on Jan. 6 in a Louisiana hospital, less than three weeks before the second Donald Trump administration’s inauguration.

When it comes to the growing potential for a bird flu outbreak, the key question is whether the new Trump administration has the political will to prioritize Americans’ health. Trump’s

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even probable.

The U.S. Department of Health and Human Services (HHS) has announced $590 million in funding to Moderna to expedite the development of mRNA-based vaccines aimed at combating

On your first day in office, you signed an executive order to withdraw the U.S. from membership in the World Health Organization (WHO). By a joint resolution of Congress in 1948, you are required to give 1-year's notice of the intention to withdraw and to pay WHO all obligated funds.

When a pathogen — any organism that causes a disease — jumps species, scientists get nervous because its genetic makeup can reconfigure and become more transmissible or lethal.

The U.S. Department of Health and Human Services (HHS) announced plans to invest $211 million in the Rapid Response Partnership Vehicle (RRPV) Consortium to bolster mRNA vaccine

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu strains, to ensure the United States is better prepared for future potential pandemics, according to a recent HHS news release.